Stay updated on Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.

Latest updates to the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a new page revision. No substantive content changes are evident.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now shows Revision: v3.6.2, indicating a minor, administrative update to the listing's versioning rather than changes to study information.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page adds new navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label. It also explicitly states that recruitment is closed and updates the revision tag to v3.6.0.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5 in the footer, signaling a new version of the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a deployed update to the page's version. This change is at the metadata level and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check67 days agoChange DetectedTaoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the list of trial locations, updating the geographic sites where participants may enroll. This changes the geographic coverage of recruitment sites for the study.SummaryDifference0.0%

Stay in the know with updates to Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.